2025-11-17T18:20:15-06:00 2024-12-31 262246506 APERCEN PARTNERS LLC 314 LYTTON AVE PALO ALTO CA 94301 990PF 2024-01-01 261586986 BRIGER FOUNDATION FOR ONCOLOGY RESEARCH INC PETE 6508047100 314 LYTTON AVE PALO ALTO CA 94301 PETER L BRIGER JR PRESIDENT 6508047100 2025-11-17 1 1 TOM M VAN LOBEN SELS P00447955 6508047100 2024 2025-03-06 01:10:19Z X 6047479 X 9643135 356554 374180 -69445 9573691 9431190 9930244 9805370 0 0 0 655084 0 607425 53815 29798 29799 2444409 0 1567316 140000 0 0 152122 55558 107922 3445430 85356 2312462 7883095 7241747 11328525 85356 9554209 -1398281 9720014 4806717 3833189 3833189 98205 98205 178238 1866085 1866085 0 250000 250000 4984955 6047479 6047479 23719 1040794 641348 0 45000 23719 1727142 X 4961236 4320337 4961236 4320337 4984955 6047479 4961236 -1398281 757382 4320337 0 4320337 PUBLICLY TRADED SECURITIES 9573691 142501 9431190 9431190 9431190 135108 0 135108 0 135108 96373 0 45000 0 141373 X 0 6265 6265 0 0 0 0 0 0 0 0 0 0 0 1 1 CA DE 1 0 1 0 0 1 N/A APERCEN PARTNERS LLC 6508047100 314 LYTTON AVE PALO ALTO CA 94301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 PETER L BRIGER JR 314 LYTTON AVE PALO ALTO CA 94301 PRESIDENT/TREASURER/DIRECTOR 2.00 0 0 0 DEVON BRIGER 314 LYTTON AVE PALO ALTO CA 94301 VICE PRESIDENT/SECRETARY/DIRECTOR 2.00 0 0 0 NONE 0 ALLOY THERAPEUTICS INC 275 SECOND AVE STE 200 WALTHAM MA 02451 RESEARCH SUPPORT 572855 ARNOLD & PORTER KAYE SCHOLER LLP 601 MASSACHUSETTS AVE NW WASHINGTON DC 20001 LEGAL 551301 PERSPECTIVE GROUP LLC 307 WASHINGTON ST WESTWOOD MA 02090 EXECUTIVE SEARCH 283333 TEMPUS AI INC 600 W CHICAGO AVE STE 510 CHICAGO IL 60654 RESEARCH SUPPORT 225887 TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 RESEARCH SUPPORT 173000 4 BREAKBIO CORP - SIMPLE AGREEMENT FOR FUTURE EQUITY (SAFE) IN AN EARLY-STAGE BIOTECHNOLOGY COMPANY THAT IS UTILIZING ARTIFICIAL INTELLIGENCE TECHNOLOGY TO ANALYZE A PATIENT'S UNIQUE TUMOR MUTATIONS TO IDENTIFY TUMOR-ASSOCIATED NON-MUTATED ANTIGENS AND NEOANTIGENS, AND DESIGN PERSONALIZED VACCINES THAT PRIME THE IMMUNE SYSTEM TO TARGET AND DESTROY THESE ANTIGENS, ALL OF WHICH FURTHERS THE FOUNDATION'S MISSION OF BRINGING NEW CANCER IMMUNOTHERAPIES TO PATIENTS AS QUICKLY AND EFFICIENTLY AS POSSIBLE. 250000 250000 0 7082452 1866085 8948537 0 0 8948537 134228 8814309 440715 440715 135108 135108 305607 0 305607 0 305607 9554209 250000 9804209 305607 0 0 1638502 372788 242263 233380 2486933 9804209 0 0 0 305607 9498602 0 0 11985535 0 0 0 0 0 0 1638502 10347033 372788 242263 233380 9498602 PETER L BRIGER JR X COLLIER SERVICES FOUNDATION INC 160 CONOVER RD WICKATUNK NJ 07765 SO I GENERAL SUPPORT 2000 ISRAEL WATER POLO ASSOCIATION WINGATE INSTITUTE NETANYA IS 4290200 NC GENERAL SUPPORT 35000 LA JOLLA INSTITUTE FOR IMMUNOLOGY 9420 ATHENA CIRCLE LA JOLLA CA 92037 PC LEIOMYOSARCOMA RESEARCH 1687786 PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY 1 LETTERMAN DR STE D3500 SAN FRANCISCO CA 94129 PC IMMUNOTHERAPY RESEARCH INITIATIVE 500000 THE MILKEN INSTITUTE 1250 FOURTH ST 2ND FL SANTA MONICA CA 90401 PC ACCELERATING THERAPY DEVELOPMENT FOR UTERINE LEIOMYOSARCOMA 16961 UNIVERSITY OF CALIFORNIA SAN FRANCISCO FOUNDATION 2001 THE EMBARCADERO 3RD FL SAN FRANCISCO CA 94133 PC ENGINEERING A NEXT-GEN CELL THERAPY FOR LEIOMYOSARCOMA 5000000 7241747 MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVE NE49-3142 CAMBRIDGE MA 02139 PC WORK ON UTERINE LEIOMYOSARCOMA 228129 PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY 1 LETTERMAN DR STE D3500 SAN FRANCISCO CA 94129 PC IMMUNOTHERAPY RESEARCH INITIATIVE 433720 661849 14 356554 18 -69445 ALTERNATIVE INVESTMENTS 900099 -138808 14 138808 -138808 425917 0 287109 0 0 0 0 0 0 0 0 0 0 X X 1 PETER L BRIGER JR 314 LYTTON AVE PALO ALTO CA 94301 3699382 X X 2 FPB MANAGEMENT LP 314 LYTTON AVE PALO ALTO CA 94301 5943753 X X 1 PUBLICLY TRADED SECURITIES 3699382 2024-12-23 2 PUBLICLY TRADED SECURITIES 5943753 2024-02-27 ACCOUNTING FEES 53815 29798 29799 ISRAEL WATER POLO ASSOCIATION WINGATE INSTITUTE NETANYA IS 4290200 2024-05-06 35000 GENERAL SUPPORT 35000 NONE 11/13/25 BREAKBIO CORP 333 SE 2ND AVE 29TH FL MIAMI FL 33131 2024-10-18 250000 PROGRAM-RELATED INVESTMENT - SIMPLE AGREEMENT FOR FUTURE EQUITY IN AN EARLY-STAGE BIOTECHNOLOGY COMPANY THAT IS UTILIZING ARTIFICIAL INTELLIGENCE TECHNOLOGY IN CANCER RESEARCH 250000 NONE 11/13/25 CERBERUS SUPPLY CHAIN FUND LP FMV 1866085 1866085 LEGAL FEES 655084 0 607425 PROGRAM RELATED INVESTMENT 250000 250000 ALTERNATIVE INVESTMENTS 44300 55558 0 EVENTS 99496 0 99496 OTHER EXPENSES 8326 0 8426 UNREALIZED GAIN ON INVESTMENT 757382 DEFERRED TAX LIABILITY 0 6000 EXCISE TAX PAYABLE 0 39000 EXECUTIVE SEARCH 284208 0 284208 RESEARCH SUPPORT 2160201 0 1283108 FPB MANAGEMENT LP 314 LYTTON AVE PALO ALTO CA 94301 EXCISE TAX 140000 0 0